See also this year's filing and all EDGAR filings for this company.
PDF Report 0001587221_2022_Zosano_Pharma_Corp.pdf
Logs
Graph
Absolute values for 0001587221, Zosano Pharma Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,609,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 32,557,000 |
| 3 | remainder_Assets | 4,224,000 |
| 4 | LiabilitiesCurrent | 11,133,000 |
| 5 | LiabilitiesNoncurrent | 3,312,000 |
| 6 | remainder_Liabilities | 970,000 |
| 7 | CostOfGoodsAndServicesSold | 796,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,547,000 |
| 9 | ResearchAndDevelopmentExpense | 20,974,000 |
| 10 | remainder_Expenses | 189,000 |
| 11 | remainder_Revenues | 785,000 |
| 12 | remainder_NetIncome | 1,796,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 48,390,000 |
| 1 | Liabilities | 15,415,000 |
| 2 | Expenses | 32,506,000 |
| 3 | Revenues | 785,000 |
| 4 | StockholdersEquity | 32,975,000 |
| 5 | NetIncome | -29,925,000 |
| 6 | ComprehensiveNetIncome | -29,925,000 |
| 7 | BaseVar | 49,446,000 |
| 8 | EconomicCapitalRatio | 0.840 |
Edgar->Model Mapping
Feature Distribution
Change over Time
